Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zila Nutraceuticals was a specialized health and nutrition company best known for its flagship product, Ester-C, a patented form of Vitamin C. The company focused on developing nutritional supplements designed for improved absorption and gentleness on the digestive system compared to standard ascorbic acid. In 2006, Zila Nutraceuticals was acquired by NBTY, Inc. (now Nature's Bounty, a part of Nestlé Health Science) for approximately $37.5 million. The acquisition allowed NBTY to integrate the globally recognized Ester-C brand into its extensive portfolio of health and wellness products. The company's operations were primarily based in Prescott, Arizona, where it managed the research and commercialization of its proprietary vitamin formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zila Nutraceuticals.